223 related articles for article (PubMed ID: 8536297)
1. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally.
Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R
Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks.
Sarchielli P; Alberti A; Codini M; Floridi A; Gallai V
Cephalalgia; 2000 Dec; 20(10):907-18. PubMed ID: 11304026
[TBL] [Abstract][Full Text] [Related]
3. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
[TBL] [Abstract][Full Text] [Related]
4. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
6. Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients.
Jang MU; Park JW; Kho HS; Chung SC; Chung JW
Oral Dis; 2011 Mar; 17(2):187-93. PubMed ID: 20659258
[TBL] [Abstract][Full Text] [Related]
7. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
9. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
[TBL] [Abstract][Full Text] [Related]
11. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].
Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S
Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides as a Marker for Chronic Headache.
Riesco N; Cernuda-Morollón E; Pascual J
Curr Pain Headache Rep; 2017 Apr; 21(4):18. PubMed ID: 28281109
[TBL] [Abstract][Full Text] [Related]
13. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome.
Boras VV; Savage NW; Brailo V; Lukac J; Lukac M; Alajbeg IZ
Med Oral Patol Oral Cir Bucal; 2010 May; 15(3):e427-31. PubMed ID: 20038912
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
15. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
16. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis.
Alstergren P; Appelgren A; Appelgren B; Kopp S; Lundeberg T; Theodorsson E
Arch Oral Biol; 1995 Feb; 40(2):127-35. PubMed ID: 7540832
[TBL] [Abstract][Full Text] [Related]
17. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.
Goadsby PJ; Edvinsson L; Ekman R
Ann Neurol; 1990 Aug; 28(2):183-7. PubMed ID: 1699472
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
20. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura.
Gallai V; Floridi A; Mazzotta G; Codini M; Tognoloni M; Vulcano MR; Sartori M; Russo S; Alberti A; Michele F; Sarchielli P
Acta Neurol Scand; 1996 Aug; 94(2):151-60. PubMed ID: 8891062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
